Artificial Intelligence (AI) is transforming industries, and drug development is no exception. The regulatory lifecycle, a critical part of therapeutic drug development, offers numerous opportunities for AI to streamline processes, reduce errors, and accelerate time to market.How do you effectively incorporate AI into this complex lifecycle? It requires a thoughtful approach and a clear framework to ensure success, which we present here as five key elements.
Commentary
The regulatory lifecycle + AI
Related resources
Product brochure
The Weave Platform
An AI-native platform built for regulatory teams — from first program planning through every health authority interaction.
Read more
Release note
Weave Platform June 2026 release notes
The June 2026 Weave Platform release expands support for global submissions, introduces new HAQ Manager capabilities, and gives Admin users…
Read more
Release note
Weave Platform May 2026 release notes
The May 2026 Weave Platform release introduces dossier document import, flexible dossier enhancements, and updates to HAQ Manager that help…
Read more
Release note
Weave Platform April 2026 release notes
The April 2026 Weave Platform release introduces NDA submission support and updates to HAQ Manager that help teams streamline submission…
Read more